Vectura Group PLC

Vectura Group PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)119.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.43m
  • 1 Year change+27.68%
  • Beta0.3656
Data delayed at least 20 minutes, as of May 12 2021 16:45 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Wednesday, Vectura Group PLC (VEC:LSE) closed at 119.00, -9.57% below its 52-week high of 131.60, set on Jan 20, 2021.
52-week range
84.60Jun 08 2020131.60Jan 20 2021
Markit short selling activity
Previous close119.00
Average volume1.08m
Shares outstanding596.61m
Free float563.85m
P/E (TTM)5.90
Market cap709.97m GBP
EPS (TTM)0.2016
Data delayed at least 20 minutes, as of May 12 2021 16:45 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Vectura Group PLC shares was Hold at 115.00 on 15 Sep 2020Read the full article

Board of Directors


Bruno Angelici, Non-Executive Chairman


Will Downie, Chief Executive Officer


Paul Fry, Chief Financial Officer


Thomas Werner, Senior Independent Non-Executive Director


Kevin Matthews, Non-Executive Director


Per-Olof Andersson, Non-Executive Director


Juliet Thompson, Non-Executive Director


Head Office:
Vectura Group plc
One Prospect West 
SN14 6FH
General enquiries
E: info@vectura.com
T: +44 (0)1249 667700
F: +44 (0)1249 667701

Investor Relations & Analysis:
Elizabeth Knowles
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.